Feasibility of Personalized Neoantigen Vaccines Plus Pembrolizumab for Advanced HCC
Modified Gustave Roussey Immune Score Detects ICI Response in BTC
Effects of PD-1 Inhibitors on Real-world Treatment Patterns, Outcomes in Advanced HCC